跳至主要内容
临床试验/NCT04688905
NCT04688905进行中(未招募)不适用

Diagnosestellung Der Herzinsuffizienz Mit Erhaltener Ejektionsfraktion Bei Patienten Mit Unklarer Belastungsdyspnoe - Validierung Gegen Den Invasiven Goldstandard (Diagnose-HFpEF)

University of Leipzig1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30
试验地点
1
主要终点
HFpEF-positive patients

研究概览

简要总结

Invasive diagnosis of heart failure with preserved ejection fraction (HFpEF) in patients with unexplained dyspnea NYHA II-III compared to other diagnostic tools

详细描述

Multiple diagnostic tests, including stress tests and the invasive conduction of left ventricular pressure-volume loops via conductance catheter (as gold standard) will be performed in patients with unexplained dyspnea NYHA II-III in order to identify patients with a heart failure with preserved ejection fraction (HFpEF). The results will be compared to previously reported diagnostic scores such as the H2FPEF and the HFA-PEFF score.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • dyspnea NYHA II-III
  • age 18-90 years
  • left ventricular ejection fraction ≥ 50%
  • ability to give informed consent

排除标准

  • unstable cardiac disease with acute decompensation
  • documented former LVEF ≤ 40%
  • heart valve disease with medium or high grade insufficiency or stenosis
  • coronary heart disease with hemodynamically relevant coronary stenosis
  • specific cardiomyopathia
  • acute or chronic cardiac inflammation (myocarditis, pericarditis)
  • former heart transplantation
  • relevant pulmonary disease (e.g. COPD) assumably causing the dyspnea
  • FEV1/VC < 70%
  • hemoglobin < 5 mmol/l
  • pregnant or nursing women
  • contraindication for one of the diagnostic tests

结局指标

主要结局

HFpEF-positive patients

时间窗: Within one day

Percentage of patients with invasively diagnosed heart failure with preserved ejection fraction

次要结局

  • H2FPEF score(Within two days)
  • Difference in MRI parameters(Within two days)
  • Difference in pulmonary artery pressure (right heart catheter)(Within two days)
  • HFA-PEFF score(Within two days)
  • Difference in DPVQ (echocardiographic) after one year(1 year)
  • Difference in E/E' (echocardiographic) after one year(1 year)
  • Difference in E/E' (echocardiographic)(Within two days)
  • Difference in DPVQ (echocardiographic)(Within two days)
  • Difference in GLS (echocardiographic)(Within two days)
  • Difference in wedge pressure (right heart catheter)(Within two days)
  • Difference in GLS (echocardiographic) after one year(1 year)

研究者

发起方
University of Leipzig
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rolf Wachter

Professor

University of Leipzig

研究点 (1)

Loading locations...

相似试验